TITLE

MEDICO-DENTAL CASE RECORDS: FIFTH REPORT

AUTHOR(S)
PALMER, JR., BISSELL B.; CARR, MALCOLM W.
PUB. DATE
February 1928
SOURCE
Journal of Dental Research;Feb1928, Vol. 8 Issue 1, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents a case study involving a 36-year-old French man who was admitted to the hospital on November 22, 1921 complaining of severe occipital and orbital headache and back pain. The patient had diminished reflexes and showed retinal hemorrhages in the eyes. He was diagnosed with acute hemorrhagic meningitis due to streptococcus viridans. Treatment and gradual improvement of the patient's condition are detailed. The original condition was thought to be caused by endarteritis.
ACCESSION #
36494378

 

Related Articles

  • Meningococcal disease: R.Ph.s play key role. Breu, Joe // Drug Topics;5/20/96, Vol. 140 Issue 10, p35 

    Reports on the American Academy of Pediatrics' (AAP) issuance of treatment recommendations for meningococcal disease. Pharmacists' role in the treatment process.

  • Meningitis becomes resistant to drugs. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);10/03/98, Vol. 317 Issue 7163, p902 

    States that the strains of type B Neisseria meningitidis, is becoming resistant to the drug which is commonly used to treat the disease. Details on the research carried out by scientists at the Pasteur Institute in Paris, France; What N meningitidis is susceptible to; Comments from Dr. Mary...

  • Meningococcal septicemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Bjorvatn, Bjarne; Bjertnaes, Lars; Fadnes, Hans Olav; Flaegstad, Trond; Gutteberg, Tore Jarl; Kristiansen, Bjorn-Erik; Pape, Jan; Rekvig, Ole Petter; Osterud, Bjarne; Aanderud, Leif // British Medical Journal (Clinical Research Edition);2/11/1984, Vol. 288 Issue 6415, p439 

    Examines the use of plasmapheresis, leucapheresis and blood exchange in the treatment of meningococcal septicaemia in Norway. Activation of blood cells by endotoxin; Consideration of the activation as the factor for the pathophysiological changes; Tolerance of the disease on the combined...

  • Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action. Jarvis, Joseph N.; Lawn, Stephen D.; Wood, Robin; Harrison, Thomas S. // Clinical Infectious Diseases;12/15/2010, Vol. 51 Issue 12, p1463 

    A letter to the editor is presented in response to the article regarding the effectiveness of serum cryptococcal antigen (CRAG) screening in patients with cryptococcal meningitis.

  • MenHibrix Vaccine Approved.  // Monthly Prescribing Reference;Jul2012, Vol. 28 Issue 7, pA6 

    The article informs about the approval of MenHibrix from GlaxoSmithKline for the treatment of those invasive diseases that are caused by Neisseria meningitidis sero groups C and Y and Haemophilus influenzae type b in children.

  • Meningococcal Polysaccharide Vaccines.  // Annals of Internal Medicine;Feb76, Vol. 84 Issue 2, p179 

    Summarizes guidelines and recommendations by the Public Health Service Advisory Committee on Immunization Practices of the U.S. Department of Health, Education and Welfare concerning polysaccharide vaccines for meningococcal disease. Role of the antigens in the control of meningococcal disease...

  • Empiric antibiotic in meningococcal disease. Pinkowish, Mary Desmond // Patient Care;8/15/2000, Vol. 34 Issue 15, p19 

    Determines whether empiric antibiotics given coincidentally to patients with unsuspected meningococcal disease (UMD) changed the course of illness. Difficulty in differentiating between viral infections and UMD in febrile children; Fear of overlooking a case of meningococcal disease; Treatment...

  • IEFECTO DE LA IRRADIACION CON Co-60 EN LA GAMMAGLOBULINA HIPERINMUNE ANTIMENINGOCOCCICA. Galguera, M.; Mart�nez, S.; Campos, C.; Sierra, G.; Armet, A.; Fern�ndez, R.; Le Riverend, E.; Padr�n, E. // Nucleus;1990, Issue 8, p3 

    Gammaglobulin from voluntary blood donors immunized with the Cuban BC antimeningococcus vaccine is now being used in our country for the treatment of the meningococcus disease. This study of the effect of Co-60 irradiation on antimeningococcus gammaglobulin was carried out to try to eliminate...

  • Drug use in acute meningococcal disease. Cathie, K.; Levin, M.; Faust, S. N. // Archives of Disease in Childhood -- Education & Practice Edition;Oct2008, Vol. 93 Issue 5, p151 

    The article explains conventional and experimental therapies for meningococcal diseases which still cause high mortality in children despite success of vaccination programme against serogroup C sickness. Drugs available in high income countries, such as pre-hospital or intravenous antibiotics...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics